Search research articles
Contact Us
Filters
Showing results (31-40 of 62) with videos related to
Page
of 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2004
Heterogeneous expression of interleukin-18 and its receptor in B-cell lymphoproliferative disorders deriving from naive, germinal center, and memory B lymphocytes
Irma Airoldi, Lizzia Raffaghello, Claudia Cocco, et al.
Frontiers in Immunology
|
September 15, 2025
Bone marrow-derived extracellular vesicles from multiple myeloma patients promote adaptive immune dysfunction via HLA-G, PD-1, and PD-L1
Debora Soncini, Danilo Marimpietri, Francesco Ladisa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 7, 2006
CXCL12 does not attract CXCR4+ human metastatic neuroblastoma cells: clinical implications
Irma Airoldi, Lizzia Raffaghello, Erich Piovan, et al.
Oncotarget
|
February 2, 2015
Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer
Irma Airoldi, Maria Grazia Tupone, Silvia Esposito, et al.
Frontiers in Immunology
|
February 16, 2026
The gamma delta T/NK cell product GADEKILL as a novel immunotherapeutic tool for neuroblastoma patients: role of B7H6 and BTN2A1 in tumor cell killing
Fabio Morandi, Martina Della Lastra, Fabio Pastorino, et al.
Cancer Letters
|
June 1, 2005
Mechanisms of immune evasion of human neuroblastoma
Lizzia Raffaghello, Ignazia Prigione, Irma Airoldi, et al.
Oncotarget
|
December 15, 2015
IL-27 induces the expression of IDO and PD-L1 in human cancer cells
Grazia Carbotti, Gaia Barisione, Irma Airoldi, et al.
Cell Transplantation
|
February 28, 2026
A novel GMP-manufactured medicinal product candidate composed of NK and γδ T cells as adjunct immunotherapy for hematopoietic stem cell transplantation
Fabio Morandi, Martina Della Lastra, Gino Tripodi, et al.
Oncotarget
|
April 1, 2014
The antitumor potential of Interleukin-27 in prostate cancer
Emma Di Carlo, Carlo Sorrentino, Alessia Zorzoli, et al.
Blood
|
July 31, 2010
Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells
Claudia Cocco, Sara Canale, Chiara Frasson, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 62) with videos related to
Sort By:
Page
of 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2004
Heterogeneous expression of interleukin-18 and its receptor in B-cell lymphoproliferative disorders deriving from naive, germinal center, and memory B lymphocytes
Irma Airoldi, Lizzia Raffaghello, Claudia Cocco, et al.
Frontiers in Immunology
|
September 15, 2025
Bone marrow-derived extracellular vesicles from multiple myeloma patients promote adaptive immune dysfunction via HLA-G, PD-1, and PD-L1
Debora Soncini, Danilo Marimpietri, Francesco Ladisa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 7, 2006
CXCL12 does not attract CXCR4+ human metastatic neuroblastoma cells: clinical implications
Irma Airoldi, Lizzia Raffaghello, Erich Piovan, et al.
Oncotarget
|
February 2, 2015
Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer
Irma Airoldi, Maria Grazia Tupone, Silvia Esposito, et al.
Frontiers in Immunology
|
February 16, 2026
The gamma delta T/NK cell product GADEKILL as a novel immunotherapeutic tool for neuroblastoma patients: role of B7H6 and BTN2A1 in tumor cell killing
Fabio Morandi, Martina Della Lastra, Fabio Pastorino, et al.
Cancer Letters
|
June 1, 2005
Mechanisms of immune evasion of human neuroblastoma
Lizzia Raffaghello, Ignazia Prigione, Irma Airoldi, et al.
Oncotarget
|
December 15, 2015
IL-27 induces the expression of IDO and PD-L1 in human cancer cells
Grazia Carbotti, Gaia Barisione, Irma Airoldi, et al.
Cell Transplantation
|
February 28, 2026
A novel GMP-manufactured medicinal product candidate composed of NK and γδ T cells as adjunct immunotherapy for hematopoietic stem cell transplantation
Fabio Morandi, Martina Della Lastra, Gino Tripodi, et al.
Oncotarget
|
April 1, 2014
The antitumor potential of Interleukin-27 in prostate cancer
Emma Di Carlo, Carlo Sorrentino, Alessia Zorzoli, et al.
Blood
|
July 31, 2010
Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells
Claudia Cocco, Sara Canale, Chiara Frasson, et al.
Page
of 7